NASDAQ: PMD - Psychemedics Corporation

Rentabilidad a seis meses: +13.62%
Sector: Healthcare

Calendario de promoción Psychemedics Corporation

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, Fentanyl, and alcohol.

más detalles
Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

IPO date 1994-02-17
ISIN US7443752057
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 5.83
Дивиденд ао 0.14
Сайт https://www.psychemedics.com
Цена ао 3
Cambio de precio por día: 0% (2.67)
Cambio de precio por semana.: 0% (2.67)
Cambio de precio por mes: +14.1% (2.34)
Cambio de precio en 3 meses.: +14.59% (2.33)
Cambio de precio en seis meses: +13.62% (2.35)
Cambio de precio por año: -9.8% (2.96)
Cambio de precio en 3 años.: -63.02% (7.22)
Cambio de precio en 5 años.: -70.88% (9.17)
Cambio de precio en 10 años.: 0% (2.67)
Cambio de precio desde principios de año.: -16.82% (3.2099)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 0.7351 10
P/BV 2.43 6
P/E 0 0
EV/EBITDA -66.05 0
Total: 5.25

Eficiencia

Nombre Significado Calificación
ROA, % -31.3 0
ROE, % -62.26 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0.5714 5.71
Total: 3.2

Deber

Nombre Significado Calificación
Debt/EBITDA -9.16 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % -41.38 0
Rentabilidad Ebitda, % -108.37 0
Rentabilidad EPS, % -358.92 0
Total: 0
Más detalles

Instituciones Volumen Compartir, %
22NW, LP 274418 4.73
Renaissance Technologies, LLC 265563 4.57
Vanguard Group Inc 251283 4.33
RBF Capital, LLC 142142 2.45
Ancora Advisors, Llc 78173 1.35
Blackrock Inc. 77267 1.33
Wedbush Securities Inc 48664 0.84
Geode Capital Management, LLC 36596 0.63
Dimensional Fund Advisors LP 36117 0.62
Crawford Investment Counsel, Inc. 20098 0.35



Supervisor Título profesional Pago año de nacimiento
Mr. Brian Hullinger President, CEO & Director 361.37k 1968 (57 años)
Dr. Werner A. Baumgartner Ph.D. Founder N/A
Ms. Annette Baumgartner Founder N/A
Mr. Michael Weisenhoff Principal Financial & Accounting Manager N/A 1990 (35 años)
Ms. Shannon Shoemaker Chief Revenue Officer 187.82k
Mr. Patrick J. Kinney Jr. Secretary N/A
Ms. Daniella Mehalik Vice President of Finance 126.41k 1990 (35 años)

DIRECCIÓN: United States, Acton. MA, 289 Great Road - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.psychemedics.com